Reneo Pharmaceuticals Inc (RPHM) is higher by 13.57% Wednesday In Premarket Trading

Reneo Pharmaceuticals Inc (RPHM) is up Wednesday morning, with the stock increasing 13.57% in pre-market trading to 1.59. RPHM's short-term technical score of 22 indicates that the stock has traded less bullishly over the last month than 78% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, RPHM ranks higher than 38% of stocks. Reneo Pharmaceuticals Inc has fallen 77.49% over the past month, closing at $6.00 on November 29. During this period of time, the stock fell as low as $1.34 and as high as $7.76. RPHM has an average analyst recommendation of Sell. The company has an average price target of $6.89.

RPHM has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on RPHM!

See Full RPHM Report

Reneo Pharmaceuticals Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 112 by this metric, RPHM ranks better than 112% of stocks.

Important Dates for Investors in RPHM:

-Reneo Pharmaceuticals Inc is set to release earnings on 2024-02-11. Over the last 12 months, the company has reported EPS of $-2.38. -We do not have a set dividend date for Reneo Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Reneo Pharmaceuticals Inc (RPHM)